Congratulations Nginache Nampota Nkomba for receiving the 2024 Maurice R. Hilleman Early-Stage Career Investigator Award! Nginache is doing incredible work to #TakeOnTyphoid🙌🏾👏🏼 nfid.org/award/maurice-… NFID

📰 In the latest #TakeOnTyphoid newsletter, updates on: ➡️ #Typhoid vaccinations in #Pakistan ➡️ Financial costs of typhoid for families & hospitals ➡️ A new tool to track drug resistance ➡️ Recent accolades of Nginache Nampota Nkomba & Megan Carey ...and more! coalitionagainsttyphoid.org/take-on-typhoi…

Researchers found that #typhoid conjugate vaccines are safe and well tolerated in children exposed to #HIV, which means these children can follow the routine immunization schedule in their country. #VaccinesWork coalitionagainsttyphoid.org/typhoid-conjug…

Our new study on typhoid conjugate vaccines in Malawi shows a single dose of TCV is safe & produces a robust immune response in HIV-exposed and HIV-unexposed children. This is a big step toward protecting children in HIV endemic regions. #TakeonTyphoid ncbi.nlm.nih.gov/pmc/articles/P…

Good Afternoon This is the 2024 Scholarship thread. Please add any that you know. I will be updating the list with links as i get them. mp.weixin.qq.com/s/66yoE7pUZTsf…

Day 1 ASTMH . Excited to learn from other researchers in tropical medicine and looking forward to sharing some of the work I’ve been doing too! #IamTropMed #TropMed24

Spotted at ASTMH 👋 Nginache Nampota Nkomba gives her presentation, "One and two dose #typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and #HIV unexposed uninfected Malawian children." #TropMed24 Full schedule of events available online ⤵️

On day 2 at ASTMH I got to share our data on one and two dose, as well as booster dose typhoid conjugate vaccine immunogenicity from Malawi. It was a great discussion. #TakeOnTyphoid #TropMed24 Priyanka Patel Osward Nyirenda Terrie Taylor

Looking for candidates for Master’s and PhD. scholarship opportunities! Fields include Control Science & Engineering, Electrical Engineering, Civil Engineering, Hydraulic Engineering, Geological Sciences & Engineering, or Management Sciences & Engineering.

A new study in #Malawi—the first to evaluate long-term immunogenicity of #typhoid conjugate vaccines (TCV) in #Africa—can help inform decision-makers on how to prioritize TCV introduction. Read more⬇️ coalitionagainsttyphoid.org/robust-immune-… #TakeOnTyphoid Nginache Nampota Nkomba UMSOM Center for Vaccine Dev. & Global Health Malawi Liverpool Wellcome Programme

Exciting new data on #TyphoidConjugateVaccines! ✅ Sustained immunity 4 years post-vaccination (given at 9-11 months) ✅ Strong booster response at 5 years old These data are key for policy decisions. Read more: sciencedirect.com/science/articl…

📢 March issue now online featuring #rotavirus, #typhoid, #lungcancer, bipolar disorder, #AF, elective cesarean section, and much more with our editorial on the measles outbreak in the USA …all available #OpenAccess❗️ Read more here: thelancet.com/issue/S2589-53… Attribution: Getty

Coming soon! 📣 Season 2 of our Getting to Zero discussion series with episodes hosted by Sabin Rising Star winners Sangwe Clovis Nchinjoh (Sangwe Clovis, MD, MPH, MSc), Nginache Nampota-Nkomba (Nginache Nampota Nkomba), and Nicole E. Basta (Dr. Nicole E. Basta, PhD MPhil) Join their interviews with immunization leaders from

So excited to have attended #ESCMIDGlobal for the first time! I gave a talk on #typhoid #vaccine roll-out in a session on introducing vaccines in low-resource settings. The discussion format made for an engaging and thought-provoking exchange. #TakeOnTyphoid Take on Typhoid

🚨 Even with ART use, HIV still affects birth outcomes. 💡 But...viral suppression mitigates this risk! Women with well-controlled HIV had better birth outcomes, including lower risk of low birth weight in our cohort of Malawian women. Read more here: journals.lww.com/jaids/abstract…

HPV vaccination for boys in LMICs is urgent! In a cohort of 498 circumcised SMM in Nigeria: 🔹72.7% had penile HPV 🔹48.0% were high-risk strains 🔹HIV ↑ odds of penile HPV (aOR 1.93) 🔹Most prevalent HPV types (16, 51, 45, 18) are vaccine-preventable. pubmed.ncbi.nlm.nih.gov/40239119/

Honored to receive the Patricia Langenberg Endowment in Epidemiology & Women’s Health Award at the UMB School of Graduate Studies. I am grateful for this recognition and the support it provides toward my research journey. #PhDLife #Epidemiology #PublicHealth #WomenInSTEM

Excited to host Sabin Vaccine Institute’s ‘Getting to Zero’ series - join me as I talk to global health leaders about the path to eliminating vaccine preventable disease! #GettingToZero #GlobalHealth

Be sure to tune in!

Tomorrow! 📣 Dr. Matt Laurens (Matt Laurens), Professor of Pediatrics, Medicine and Pathology at University of Maryland School of Medicine and Project Director of TyVAC, joins host Ngina Nampota-Nkomba (Nginache Nampota Nkomba) for a new episode of our discussion series, Getting to Zero! The conversation will cover